{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:35:18Z","timestamp":1759991718091,"version":"3.44.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.clinbiochem.2009.02.009","type":"journal-article","created":{"date-parts":[[2009,2,22]],"date-time":"2009-02-22T04:43:33Z","timestamp":1235277813000},"page":"777-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease"],"prefix":"10.1016","volume":"42","author":[{"given":"Mohsen","family":"Kerkeni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Letaief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdellatif","family":"Achour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelhedi","family":"Miled","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois","family":"Trivin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khira","family":"Maaroufi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2009.02.009_bib1","first-page":"584","article-title":"Renal replacement therapy for diabetic end-stage renal disease. Experience of a Tunisian hospital centre","volume":"27","author":"Abderrahim","year":"2001","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib2","first-page":"403","article-title":"Epidemiology of glomerular diseases in Tunisian from 1975 to 2005. Influence of changes in healthcare and society","volume":"190","author":"Ben Ma\u00efz","year":"2006","journal-title":"Bull. Acad. Natl. Med."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.ajkd.2007.10.032","article-title":"Trends of incidence dialysis patients in Tunisia between 1992 and 2001","volume":"51","author":"Counil","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib4","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.CIR.102.11.1227","article-title":"Plasma homocysteine predicts mortality independently of tradictional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease","volume":"102","author":"Anderson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib5","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/clinchem\/47.5.887","article-title":"Oxidative stress and homocysteine in coronary artery disease","volume":"47","author":"Cavalca","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.jhh.1000803","article-title":"Homocysteine, hypertension and strok","volume":"13","author":"Perry","year":"1999","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.clinbiochem.2006.05.010","article-title":"Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease","volume":"39","author":"Kerkeni","year":"2006","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0002-9149(02)02194-X","article-title":"Usefulness of plasma vitamin B6, B12, folate, homocysteine, and creatinine in predicting outcomes in heart transplant recipients","volume":"89","author":"Nahlawi","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib9","doi-asserted-by":"crossref","first-page":"756S","DOI":"10.1093\/jn\/126.suppl_3.756S","article-title":"homocysteine and neural tube defects","volume":"126","author":"Mills","year":"1996","journal-title":"J. Nutr."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib10","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1212\/WNL.58.10.1539","article-title":"Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals","volume":"58","author":"Sachdev","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib11","first-page":"S11","article-title":"Homocysteinemia and vascular disease in end-stage renal disease","volume":"57","author":"Dennis","year":"1996","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1681\/ASN.V111134","article-title":"Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study","volume":"11","author":"Ducloux","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib13","first-page":"77","article-title":"Hyperhomocysteinemia and end-stage renal disease","volume":"10","author":"Gupta","year":"1997","journal-title":"J. Nephrol."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ki.1997.359","article-title":"Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure","volume":"52","author":"Guttormen","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib15","first-page":"53","article-title":"Homocysteine metabolism in renal failure","volume":"7","author":"Perna","year":"2004","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.mol.0000137227.54278.29","article-title":"Paraoxonase 1 activity, concentration and genotype in cardiovascular disease","volume":"15","author":"Mackness","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.RES.87.1.45","article-title":"Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis","volume":"87","author":"Jakubowski","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib18","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1074\/jbc.275.6.3957","article-title":"Calcium-dependent human serum homocysteine thiolactone hydrolyse: a protective mechanism against protein N-homocysteinylation","volume":"275","author":"Jakubowski","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-5793(01)02143-3","article-title":"Genetic determinants of homocysteine thiolactone activity in humans: implication for atherosclerosis","volume":"491","author":"Jakubowski","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib20","series-title":"Homocysteine metabolism: from Basis science to clinical medicine","first-page":"157","article-title":"Synthesis of homocysteine thiolactone in normal and malignant cells","author":"Jakubowski","year":"1997"},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib21","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1096\/fasebj.13.15.2277","article-title":"Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels","volume":"13","author":"Jakubowski","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib22","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1515\/CCLM.2003.224","article-title":"Homocysteine thiolactone and S-nitro-homocysteine mediate incorporation of homocysteine into protein in humans","volume":"41","author":"Jakubowski","year":"2003","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00018-003-3204-7","article-title":"Molecular basis of homocysteine toxicity in humans","volume":"61","author":"Jakubowski","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1023\/A:1009652011466","article-title":"Homocysteine thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features","volume":"5","author":"Mercie","year":"2000","journal-title":"Apoptosis"},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11010-006-9204-9","article-title":"Comparative study on in vitro effects of homocysteine thiolactone and homocysteine on HUVEC cells: evidence for a stronger proapoptotic and proinflammation homocysteine thiolactone","volume":"291","author":"Kerkeni","year":"2006","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib26","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1515\/CCLM.2005.177","article-title":"Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease","volume":"43","author":"Jakubowski","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib27","doi-asserted-by":"crossref","first-page":"1741S","DOI":"10.1093\/jn\/136.6.1741S","article-title":"Pathophysiological consequences of homocysteine excess","volume":"136","author":"Jakubowski","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib28","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1515\/CCLM.2007.338","article-title":"The molecular basis of homocysteine thiolactone mediated vascular disease","volume":"45","author":"Jakubowski","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib29","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.amjcard.2008.02.060","article-title":"Emerging cardiovascular risk factors that account for a significant portion of attributable mortality in chronic kidney disease","volume":"101","author":"Shishehbor","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000110876","article-title":"Mechanisms of homocysteine-induced glomerular injury and sclerosis","volume":"28","author":"Yi","year":"2008","journal-title":"Am. J. Nephro."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5551\/jat.9.133","article-title":"Serum paraoxonase (PON1) concentration in patients undergoing hemodialysis","volume":"9","author":"Suehiro","year":"2002","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib32","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1515\/CCLM.2008.164","article-title":"Serum paraoxonase 1 activities and Homocysteinemia in hemodialysis patients","volume":"46","author":"Dronca","year":"2008","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1258\/acb.2007.007066","article-title":"Hyperhomocysteinemia and parameters of antioxidative defence in Tunisian patients with coronary heart disease","volume":"45","author":"Kerkeni","year":"2008","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann. Inter. Med."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib35","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1681\/ASN.2005030226","article-title":"Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease","volume":"16","author":"Vlagopoulos","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib36","first-page":"5","article-title":"Report of a WHO scientific group","volume":"405","year":"1968","journal-title":"World. Health Organisation Tech. Rep. Ser."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5551\/jat1994.7.152","article-title":"Serum paraoxonase and arylesterase activities in hemodialysis patients","volume":"7","author":"Itahara","year":"2000","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2362.1992.tb01829.x","article-title":"Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and risk factors","volume":"22","author":"Brattstr\u00f6m","year":"1992","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0021-9150(94)05481-W","article-title":"Role of blood pressure, uric acid, and hemorhelogical parameters on plasma homocysteine concentration","volume":"114","author":"Malinow","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-2000-8096","article-title":"Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease","volume":"26","author":"Boers","year":"2000","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1258\/000456306776865232","article-title":"Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease","volume":"43","author":"Kerkeni","year":"2006","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ajcn\/72.2.315","article-title":"Homocysteine and cardiovascular disease: cause or effect?","volume":"72","author":"Brattstr\u00f6m","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ki.1997.359","article-title":"Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure","volume":"52","author":"Guttormsen","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib44","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/01.ATV.18.4.535","article-title":"Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease","volume":"18","author":"Blacher","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ki.1997.298","article-title":"Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes","volume":"52","author":"Bostom","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000057428","article-title":"Homocysteine, a new crucial element in the pathogenesis of uremic cardiovascular complications","volume":"25","author":"Perna","year":"1999","journal-title":"Miner. Electrolyte Metab."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib47","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000110876","article-title":"Mechanisms of homocysteine induced glomerular injury and sclerosis","volume":"28","author":"Yi","year":"2008","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib48","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.ki.5002031","article-title":"Homocysteine induces mesangial apoptosis via activation of p38-mitogen-activated protein kinase","volume":"71","author":"Shastry","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib49","first-page":"885","article-title":"Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans","volume":"50","author":"Lacinski","year":"2004","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib50","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/sj.ki.5000070","article-title":"Increased plasma protein homocysteinylation in hemodialysis patients","volume":"69","author":"Perna","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cca.2005.09.028","article-title":"Disruption of thiol homeostasis in plasma of terminal renal failure patients","volume":"366","author":"Wlodek","year":"2006","journal-title":"Clin. Chem. Acta"},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib52","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1523-1755.2002.kid558.x","article-title":"Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia","volume":"62","author":"Kumagai","year":"2002","journal-title":"Kdney Int."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib53","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1523-1755.2004.00960.x","article-title":"Mild hyperhomocysteinemia promotes renal hemodynamic dysfunction without histopathologic changes in adult rats","volume":"66","author":"Ossani","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1152\/ajpheart.00560.2006","article-title":"Chronic NOS inhibition actuates endothelial mesenchymal transformation","volume":"292","author":"O'Riordan","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib55","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.ASN.0000053419.27133.23","article-title":"Hyperhomocysteinemia induces renal hemodynamic dysfunction: is nitric oxide involved?","volume":"14","author":"Fisher","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib56","first-page":"1444","article-title":"Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium","volume":"41","author":"Stranger","year":"2003","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib57","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3317\/jraas.2006.039","article-title":"The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats","volume":"7","author":"Kassab","year":"2006","journal-title":"J. Renin. Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib58","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.0000039528.49161.E9","article-title":"Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease","volume":"106","author":"Minuz","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib59","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/FJC.0b013e31817ae60f","article-title":"Effect of mast cell stabilizers in hyperhomocysteinemia induced cardiac hypertrophy in rats","volume":"51","author":"Singh","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1440-1681.2007.04552.x","article-title":"Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia","volume":"34","author":"Marsillach","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.clinbiochem.2009.02.009_bib61","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/jpet.107.127357","article-title":"Cellular protection by erythropoietin: new therapeutic implications?","volume":"323","author":"Joyeux-Faure","year":"2007","journal-title":"JPET"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912009000939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912009000939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:29:41Z","timestamp":1757863781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912009000939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0009912009000939"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.02.009","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The Canadian Society of Clinical Chemists. Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}